参考文献/References:
[1] 彭玉凤,张扬南,黄常洪,等.鼻咽癌患者血清同型半胱氨酸水平与临床病理特征的相关性分析[J].现代检验医学杂志,2019,34(2):115-118.PENG Yu f e n g , ZHANG Yangnan, HUANGChanghong, et al. Correlation analysis between serumhomocysteine level of nasopharyngeal carcinomapatients and clinical pathological features [J]. Journalof Modern Laboratory Medicine, 2019,34(2):115-118.
[2] 张玲, 刘杰, 王臣玉, 等.EB 病毒Rta 优势表位抗原的克隆表达及在应用ELISA 诊断鼻咽癌中的价值[J]. 现代检验医学杂志, 2020,35(5):1-4,12.ZHANG Ling, LIU Jie, WANG Chenyu, et al. Cloningand expression of dominant epitope antigen of epsteinbarrvirus Rta protein and its application in thediagnosis of nasopharyngeal carcinoma by ELISA [J].Journal of Modern Laboratory Medicine, 2020,35(5):1-4,12.
[3] LU Chunwan, KLEMENT J D, YANG Dafeng, et al.SUV39H1 regulates human colon carcinoma apoptosisand cell cycle to promote tumor growth[J]. CancerLetters, 2020, 476 : 87-96.
[4] SHARMA M, BHAVANI C, SURESH S B, et al. Geneexpression profiling of CD34(+) cells from patientswith myeloproliferative neoplasms[J]. OncologyLetters, 2021, 21(3): 204.
[5] TAN Guixiang, WANG Xinning, TANG Yunyun, etal. PP-22 promotes autophagy and apoptosis in thenasopharyngeal carcinoma cell line CNE-2 by inducingendoplasmic reticulum stress, downregulating STAT3signaling, and modulating the MAPK pathway[J].Journal of Cellular Physiology, 2019, 234(3): 2618-2630.
[6] KANWAL R, DATT M, LIU Xiaoqi, et al. Dietaryflavones as dual inhibitors of DNA methyltransferasesand histone methyltransferases[J]. PLoS One, 2016,11(9): e0162956.
[7] LAI Weiwei, JIA Jiantao, YAN Bin, et al. Baicalinhydrate inhibits cancer progression in nasopharyngealcarcinoma by affecting genome instability andsplicing[J]. Oncotarget, 2018, 9(1): 901-914.
[8] KHAN G J, RIZWAN M, ABBAS M, et al. Pharmacologicaleffects and potential therapeutic targets of DT-13[J]. Biomed Pharmacother, 2018, 97: 255-263.
[9] CAMPION N J, ALLY M, JANK B J, et al. The molecularmarch of primary and recurrent nasopharyngealcarcinoma[J]. Oncogene, 2021, 40(10): 1757-1774.
[10] WANG Dingkun, WU Cheng, LIU Dongbo, et al.Ginsenoside Rg3 inhibits migration and invasionof nasopharyngeal carcinoma cells and suppressesepithelial mesenchymal transition[J]. BioMed ResearchInternational, 2019,2019(4): 8407683.
[11] HE Jinyong, WEI Xiaohui, LI Sijing, et al. DT-13suppresses breast cancer metastasis by modulatingPLOD2 in the adipocytes microenvironment[J].Phytomedicine : International Journal of Phytotherapyand Phytopharmacology, 2019, 59: 152778.
[12] WEI Xiaohui, LIN Sensen, LIU Yang, et al. DT-13attenuates human lung cancer metastasis via regulatingNMIIA activity under hypoxia condition[J]. OncologyReports, 2016, 36(2): 991-999.
[13] ZHANG Yanjun, SUN Zhongxing, JIA Junqi, et al.Overview of histone modification[J]. Advances inExperimental Medicine and Biology, 2021, 1283:1-16.
[14] HEALTON S E, PINTO H D, MISHRA L N, et al. H1linker histones silence repetitive elements by promotingboth histone H3K9 methylation and chromatincompaction[J]. Proceedings of the National Academyof Sciences of the United States of America, 2020,117(25): 14251-14258.
[15] ZHANG Li, TIAN Sijuan, ZHAO Minyi, et al.SUV39H1-DNMT3A-mediated epigenetic regulation ofTim-3 and galectin-9 in the cervical cancer[J]. CancerCell International, 2020, 20(1) : 457-465.
[16] RODRIGUES C, PATTABIRAMAN C, VIJAYKUMARA, et al. A SUV39H1-low chromatin state characterisesand promotes migratory properties of cervicalcancer cells[J]. Experimental Cell Research, 2019,378(2): 206-216.
[17] YAN Wenbo, GUO Yuqi, XU Fangxi, et al. Identificationof differentially methylated regions associated witha knockout of SUV39H1 in prostate cancer cells[J].Genes, 2020, 11(10) : 1188.
[18] 刘洁, 徐冰雁, 胡晶, 等. 鼻咽癌转移相关的信号通路[J]. 中国中西医结合耳鼻咽喉科杂志,2019,27(3):237-240.LIU Jie, XU Bingyan,HU Jing,et al.Signalingpathway of associated with metasis of naopharyngedcarcinoma[J].Chinese Journal of Otorhinolaryngologyin Integrative Medicine, 2019,27 (3): 237-240.
[19] VERHOEVEN Y, TILBORGHS S, JACOBS J, et al.The potential and controversy of targeting STAT familymembers in cancer[J]. Seminars in Cancer Biology,2020, 60: 41-56.
[20] YU Hua, LEE H, HERRMANN A, et al. RevisitingSTAT3 signalling in cancer: new and unexpectedbiological functions[J]. Nature Reviews Cancer, 2014,14(11): 736-746.
[21] QING Xiang, TAN Guolin, LIU Huowang, et al.LINC00669 insulates the JAK/STAT suppressor SOCS1to promote nasopharyngeal cancer cell proliferation andinvasion[J]. Journal of Experimental & Clinical CancerResearch, 2020, 39(1) : 64-80.
[22] 王莉新, 吴文斌, 胥孜杭, 等. 黄芪甲苷通过诱导M1 型巨噬细胞极化发挥抗肿瘤作用的机制[J]. 中国实验方剂学杂志,2019,25(14):19-24.WANG Lixin, WU Wenbin, XU Zihang, et al.Anti-tumor effect of astragaloside by inducing M1macrophage polarization [J]. Chinese Journal ofExperimental Traditional Medical Formulae, 2019,25(14): 19-24.
相似文献/References:
[1]李 璐,梁 辉a,陈群蓉b.鼻咽癌组织中SYK基因启动子区的甲基化分析[J].现代检验医学杂志,2015,30(02):39.[doi:10.3969/j.issn.1671-7414.2015.02.012]
LI Lu,LIANG Huia,CHEN Qun-rongb.Methylation of SYK Gene Promoter Region in Nasopharyngeal Carcinoma[J].Journal of Modern Laboratory Medicine,2015,30(06):39.[doi:10.3969/j.issn.1671-7414.2015.02.012]
[2]彭玉凤,张扬南,黄常洪,等.鼻咽癌患者血清同型半胱氨酸水平与临床病理特征的相关性分析[J].现代检验医学杂志,2019,34(02):115.[doi:10.3969/j.issn.1671-7414.2019.02.029]
PENG Yu-feng,ZHANG Yang-nan,HUANG Chang-hong,et al.Correlation Analysis between Serum Homocysteine Level ofNasopharyngeal Carcinoma Patients and Clinical Pathological Features[J].Journal of Modern Laboratory Medicine,2019,34(06):115.[doi:10.3969/j.issn.1671-7414.2019.02.029]
[3]张玲,刘杰,王臣玉,等.EB 病毒Rta 优势表位抗原的克隆表达及在应用ELISA 诊断鼻咽癌中的价值[J].现代检验医学杂志,2020,35(05):1.[doi:10.3969/j.issn.1671-7414.2020.05.001]
ZHANG Ling,LIU Jie,WANG Chen-yu,et al.Cloning and Expression of Dominant Epitope Antigen of Epstein-Barr
Virus Rta Protein and Its Application in the Diagnosis of Nasopharyngeal
Carcinoma by ELISA[J].Journal of Modern Laboratory Medicine,2020,35(06):1.[doi:10.3969/j.issn.1671-7414.2020.05.001]
[4]薛玉峰a,张会平a,王 芳b,等.鼻咽癌患者血清miR-144-3p及miR-151-3p的表达水平及临床价值[J].现代检验医学杂志,2021,36(05):65.[doi:10.3969/j.issn.1671-7414.2021.05.015]
XUE Yu-fenga,ZHANG Hui-pinga,WANG Fangb,et al.Expression and Clinical Value of Serum miR-144-3p and miR-151-3pLevels in Patients with Nasopharyngeal Carcinoma[J].Journal of Modern Laboratory Medicine,2021,36(06):65.[doi:10.3969/j.issn.1671-7414.2021.05.015]
[5]潘国刚,杨碧秀.鼻咽癌不同临床分期中白细胞介素水平表达的最新研究进展[J].现代检验医学杂志,2021,36(05):184.[doi:10.3969/j.issn.1671-7414.2021.05.040]
PAN Guo-gang,YANG Bi-xiu.Latest Research Progress on the Expression Mechanism of Interleukin inNasopharyngeal Carcinoma Different Clinical Staging[J].Journal of Modern Laboratory Medicine,2021,36(06):184.[doi:10.3969/j.issn.1671-7414.2021.05.040]
[6]顾刘雷a,顾 培b,金广浩a,等.鼻咽癌组织中LncRNA CTBP1-AS2 和miR-140-5p 水平表达与放疗疗效及预后的关系研究[J].现代检验医学杂志,2024,39(02):23.[doi:10.3969/j.issn.1671-7414.2024.02.005]
GU Liuleia,GU Peib,JIN Guanghaoa,et al.Relationship between the Expression of LncRNA CTBP1-AS2 and miR-140-5p Levels in Nasopharyngeal Carcinoma Tissues and Radiotherapeutic Effect and Prognosis[J].Journal of Modern Laboratory Medicine,2024,39(06):23.[doi:10.3969/j.issn.1671-7414.2024.02.005]